ReviewCurrent gastroenterology reports2016
Management and Complications of Short Bowel Syndrome: an Updated Review.
Review in Current gastroenterology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.Clinical pharmacokinetics · 2022Pooled it
- Tracking Anxiety in Chronic Intestinal Failure: The Role of Time in Healing.Healthcare (Basel, Switzerland) · 2025Article
- [Practical guideline for short bowel syndrome].Zeitschrift fur Gastroenterologie · 2025Review
- The Anxiety Burden in Patients with Chronic Intestinal Failure on Long-Term Parenteral Nutrition and in Their Caregivers.Nutrients · 2024Article
- Article
- A new surgical technique for short bowel syndrome.BMC surgery · 2022Article
- A rare case of eosinophilic gastrointestinal disorders with short bowel syndrome after strangulated bowel obstruction.Surgical case reports · 2022Article
- Segmental reversal of the distal small intestine in a short bowel syndrome model in piglets showed detrimental effect on weight gain.BMC gastroenterology · 2022Article
- Building gut from scratch - progress and update of intestinal tissue engineering.Nature reviews. Gastroenterology & hepatology · 2022Review
- How Broad Should Gram-Negative Coverage Be for Febrile Parenteral Nutrition Dependent Short Bowel Syndrome Patients?Journal of pediatric gastroenterology and nutrition · 2022Article
- Improvement in metabolic indices including thyroid hormones via enhanced absorption of nutrients by Teduglutide in short bowel syndrome.International journal of surgery case reports · 2022Article
- An overview of the current management of short-bowel syndrome in pediatric patients.Surgery today · 2022Review
- Oligomeric Formulas in Surgery: A Delphi and Consensus Study.Nutrients · 2021Article
- Glucagon-Like Peptide-2 Modulates Enteric Paneth Cells Immune Response and Alleviates Gut Inflammation During Intravenous Fluid Infusion in Mice With a Central Catheter.Frontiers in nutrition · 2021Article
- Bi-layered Tubular Microfiber Scaffolds as Functional Templates for Engineering Human Intestinal Smooth Muscle Tissue.Advanced functional materials · 2020Article
- The Enteric Nervous System and Its Emerging Role as a Therapeutic Target.Gastroenterology research and practice · 2020Review
- Off-Label Teduglutide Therapy in Non-intestinal Failure Patients with Chronic Malabsorption.Digestive diseases and sciences · 2019Article
- The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome.ACS pharmacology & translational science · 2019Article
- Current treatment paradigms in pediatric short bowel syndrome.Clinical journal of gastroenterology · 2018Review
- Hormonal Management of Small Bowel Failure.Clinical and translational gastroenterology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Short bowel syndrome (SBS) is defined as loss of bowel mass from surgical resection, congenital defects, or disease. Intestinal failure (IF) includes the subset of SBS unable to meet nutrition needs with enteral supplements and requires parenteral nutrition (PN). The parenteral treatment of SBS is now a half-century old. Recent pharmacologic treatment (GLP-2 analogues) has begun to make a significant impact in the care and ultimate management of these patients such that the possibility of reducing PN requirements in formerly PN-dependent patients is a now a real possibility. Finally, newer understanding and possible treatment for some of the complications related to IF have more recently evolved and will be an emphasis of this report. This review will focus on developments over the last 10 years with the goal of updating the reader to new advances in our understanding of the care and feeding of the SBS patient.
Indexed as
Identifiers
27324885What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.